Events & Presentations
Disruptive Technology in Chronic Condition Management
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform.
Dario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes.
Dario's unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and utilizes a performance-based approach to improve its users' health.
On the path to better health, Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
August 31, 2021
August 16, 2021
Augut 9, 2021
May 24, 2021
May 18, 2021
May 18, 2021
April 23, 2021
Jun 26, 2020
Click here for dedicated interview page
RCA Financial Partners, a consulting and advisory firm to data resource innovators at the critical inflection point where proven technology requires prudent financing, and DarioHealth’s (Nasdaq: DRIO) CEO Erez Raphael, and the team he hired away from Catasys, discuss the B2B development strategy on a video conference call that will be available on Tuesday July 7, 2020 at 1:00 PM EST.